BPMC
Price
$128.20
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
8.29B
24 days until earnings call
PHIO
Price
$2.40
Change
-$0.08 (-3.23%)
Updated
Jul 3 closing price
Capitalization
11.52M
Interact to see
Advertisement

BPMC vs PHIO

Header iconBPMC vs PHIO Comparison
Open Charts BPMC vs PHIOBanner chart's image
Blueprint Medicines
Price$128.20
Change-$0.00 (-0.00%)
Volume$437
Capitalization8.29B
Phio Pharmaceuticals
Price$2.40
Change-$0.08 (-3.23%)
Volume$84.05K
Capitalization11.52M
BPMC vs PHIO Comparison Chart in %
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. PHIO commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Hold and PHIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BPMC: $128.20 vs. PHIO: $2.40)
Brand notoriety: BPMC and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 0% vs. PHIO: 12%
Market capitalization -- BPMC: $8.29B vs. PHIO: $11.52M
BPMC [@Biotechnology] is valued at $8.29B. PHIO’s [@Biotechnology] market capitalization is $11.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, BPMC is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 3 TA indicator(s) are bullish while PHIO’s TA Score has 3 bullish TA indicator(s).

  • BPMC’s TA Score: 3 bullish, 6 bearish.
  • PHIO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а +0.04% price change this week, while PHIO (@Biotechnology) price change was +8.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BPMC is expected to report earnings on Oct 23, 2025.

PHIO is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($8.29B) has a higher market cap than PHIO($11.5M). BPMC YTD gains are higher at: 46.985 vs. PHIO (33.333). PHIO has higher annual earnings (EBITDA): -7.05M vs. BPMC (-66.42M). BPMC has more cash in the bank: 576M vs. PHIO (13.3M). PHIO has less debt than BPMC: PHIO (0) vs BPMC (467M). BPMC has higher revenues than PHIO: BPMC (562M) vs PHIO (0).
BPMCPHIOBPMC / PHIO
Capitalization8.29B11.5M72,078%
EBITDA-66.42M-7.05M942%
Gain YTD46.98533.333141%
P/E RatioN/A0.01-
Revenue562M0-
Total Cash576M13.3M4,331%
Total Debt467M0-
FUNDAMENTALS RATINGS
BPMC vs PHIO: Fundamental Ratings
BPMC
PHIO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
4038
P/E GROWTH RATING
1..100
6669
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHIO's Valuation (58) in the Biotechnology industry is in the same range as BPMC (81). This means that PHIO’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (56) in the Biotechnology industry is somewhat better than the same rating for PHIO (100). This means that BPMC’s stock grew somewhat faster than PHIO’s over the last 12 months.

BPMC's SMR Rating (96) in the Biotechnology industry is in the same range as PHIO (98). This means that BPMC’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's Price Growth Rating (38) in the Biotechnology industry is in the same range as BPMC (40). This means that PHIO’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's P/E Growth Rating (66) in the Biotechnology industry is in the same range as PHIO (69). This means that BPMC’s stock grew similarly to PHIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCPHIO
RSI
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
73%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEI1.060.03
+2.91%
Alset
LPLA384.117.64
+2.03%
LPL Financial Holdings
UNFI23.260.22
+0.95%
United Natural Foods
QFIN42.74N/A
N/A
Qifu Technology
FINW15.67-0.05
-0.32%
FinWise Bancorp

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-3.23%
MTNB - PHIO
50%
Loosely correlated
-2.43%
TPST - PHIO
49%
Loosely correlated
N/A
SAGE - PHIO
41%
Loosely correlated
+1.32%
IMNN - PHIO
39%
Loosely correlated
-1.24%
BPMC - PHIO
35%
Loosely correlated
N/A
More